Fermenta Biotech Ltd.
| BSE: 506414 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE225B01021 |
| BSE 00:00 | 12 Apr | 257.25 |
-13.25 (-4.90%) |
OPEN
270.00 |
HIGH
270.05 |
LOW
255.00 |
| NSE 05:30 | 01 Jan | Fermenta Biotech Ltd |
| OPEN | 270.00 |
| PREVIOUS CLOSE | 270.50 |
| VOLUME | 26447 |
| 52-Week high | 442.00 |
| 52-Week low | 218.00 |
| P/E | 15.29 |
| Mkt Cap.(Rs cr) | 757 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Fermenta Biotech Ltd. (FERMENTABIOTEC) - Financial Overview
Particulars ( cr) |
2020 | 2019 | 2018 |
| Net Sales | 299.27 | 403.45 | 12.51 |
| Operating Profit | 82.76 | 154.27 | -9.00 |
| Other Income | 12.31 | 12.34 | 0.38 |
| Interest | 20.27 | 21.30 | 10.63 |
| Depreciation | 14.94 | 11.85 | 3.83 |
| Profit Before Tax | 47.55 | 121.12 | -23.46 |
| Tax | -16.12 | 10.77 | 0.69 |
| Profit After Tax | 63.67 | 110.35 | -24.15 |
| Share Capital | 14.42 | 4.59 | 2.29 |
| Reserves | 298.18 | 244.90 | 62.43 |
| Net Worth | 312.60 | 249.49 | 64.72 |
| Loans | 231.05 | 218.19 | 150.51 |
| Gross Block | 243.53 | 208.83 | 103.17 |
| Investments | 1.11 | 8.40 | 117.53 |
| Cash | 32.37 | 90.73 | 1.57 |
| Debtors | 77.44 | 65.60 | 0.28 |
| Net Working Capital | 274.95 | 260.75 | 1.81 |
| Operating Profit Margin (%) | 27.65 | 38.24 | -71.94 |
| Net Profit Margin (%) | 21.28 | 27.35 | -193.05 |
| Earning Per Share (Rs) | 22.07 | 120.30 | 0.00 |
| Dividend (%) | 100.00 | 25.00 | 25.00 |
| Dividend Payout | 0.00 | 0.00 | 0.69 |
Quick Links for Fermenta Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
